|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Pharma Market Research Report
|
|
There has never been anything like PMR² (subscription product), which covers MR conducted on behalf of OTC, prescription, medical devices, hospitals and healthcare, pharmacies, biotech, etc. Within the world of MR, market researchers in these pharma sectors have been treated like stepchildren. Until now, every publication targeted at you has been either inordinately generic about MR or a pharma “marketing” magazine (requiring a Web search to find anything related to MR). PMR² changes all that!
Pharma MR needs and deserves better. PMR² responds to your MR role’s unique, differentiated and broad dynamics. Unlike cpg and other mainstream MR, the products and services that pharma market researchers toil for directly impact the health and longevity of consumers. The average $5.5 million spent on MR for each new pharma product is a sum larger than most annual market research department (MRD) budgets outside pharma companies.
PMR²’s goal is growing pharma MR user and provider efficiencies, effectiveness and productivity via news and profiles that spotlight emerging and implemented trends, technologies and methods. We intend to shake pharma MR from any complacency that may exist because your function can and should be contributing more!
|
Similar Products
• Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
Published Jul 2010 by MarketsandMarkets
• South Africa Pharmaceuticals and Healthcare Report Q3 2010
Published Jul 2010 by Business Monitor International
• Venezuela Pharmaceuticals and Healthcare Report Q3 2010
Published Jul 2010 by Business Monitor International
• United Kingdom Pharmaceuticals and Healthcare Report Q3 2010
Published Jul 2010 by Business Monitor International
• Czech Republic Pharmaceuticals and Healthcare
Published Jul 2010 by Business Monitor International
• Belarus Pharmaceuticals and Healthcare Report Q3 2010
Published Jul 2010 by Business Monitor International
• U.S. Opioid Pain Management Market
Published Jul 2010 by Frost & Sullivan
• Stakeholder Opinions: Ovarian Cancer - Approaching the era of molecular targeted therapy
Published Jul 2010 by Datamonitor
• Bristol-Myers Squibb Co.: PharmaVitae Profile
Published Jul 2010 by Datamonitor
• The Funding Landscape for Small Biopharma Ventures, 2010-2015: Trends, strategies and priorities
Published Jul 2010 by Business Insights
|
|
|
|
0 items
Questions About This Report
E-mail a Colleague
Printable Page
Fax Your Order